Table 1.
Compounds No. | Ar | VEGFR2/KDR Inhibitory Rate@10μM (%) | IC50(μM) a | |||
---|---|---|---|---|---|---|
A549 | Hela | MCF-7 | PC-3 | |||
6a | 23.6% ± 12.9% | >100 | >100 | >100 | >100 | |
6b | 54.0% ± 2.7% | 65.86 ± 2.01 | >100 | 72.43 ± 1.96 | >100 | |
6c | 75.8% ± 5.5% | 27.04 ± 1.43 | >100 | >100 | 25.35 ± 1.73 | |
6d | 61.3% ± 9.6% | 86.91 ± 2.03 | >100 | 80.56 ± 2.04 | >100 | |
6e | 31.4% ± 7.2% | >100 | >100 | >100 | 68.87 ± 2.14 | |
6f | 46.6% ± 1.8% | 32.59 ± 1.51 | 63.92 ± 1.81 | 16.54 ± 1.22 | 17.97 ± 1.56 | |
9a | <20.0% | >100 | 42.43 ± 1.93 | 17.19 ± 1.54 | ND c | |
9b | <20.0% | >100 | >100 | >100 | ND | |
9c | <20.0% | 57.42 ± 1.89 | >100 | >100 | ND | |
9d | <20.0% | 33.22 ± 1.82 | 24.65 ± 1.69 | >100 | ND | |
9e | <20.0% | >100 | 44.32 ± 1.75 | 69.25 ± 1.96 | ND | |
Sorafenib b | - | 94.9% ± 1.1% | 6.53 ± 0.82 | 8.08 ± 0.91 | 4.21 ± 0.62 | 11.05 ± 1.07 |
Staurosporine b | - | 97.3% ± 2.82% | ND | ND | ND | ND |
a The values are an average of two separate determinations; b Used as a positive controls; c ND: Not determined.